Events

Meet biopharma finalists for MedCity virtual INVEST event: Register now for Earlybird tickets while they last

MedCity News will host its INVEST conference online the week of July 20. These five biopharma companies will take part in the INVEST Pitch Perfect startup competition.

Our annual INVEST conference will be held as a virtual event this year. We will highlight the seismic changes in healthcare from July 20-24 and spotlight top startups and growth stage companies and how healthcare innovation is contending with the coronavirus public health crisis.

Check out the agenda here and register today. Early-bird Registration for MedCity Invest 2020 is available now for $49 if you register with the code MCN50. Full price tickets are $99. Companies can also opt to purchase 10 tickets for a corporate group rate of $399.

Meet the biopharma startups at INVEST Pitch Perfect:

 

Biolife4D is applying 3D bioprinting to developing a patient-specific, fully functioning heart with the patient’s own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ                              transplant methods.

CEO: Steven Morris

Headquarters: Buffalo Grove, IL

Libera Bio is applying decades of research in nanomedicine to deliver whole antibodies to previously “undruggable” intracellular cancer targets, starting with Kirsten rat sarcoma viral oncogene homolog (KRAS). This mutation is found in up to 25% of all human tumors.

CEO: Olivier Jarry

Headquarters: US and Spain

 

Moonlight Therapeutics is a pre-clinical stage biopharmaceutical company developing an immunotherapy for food allergies.

CEO: Samir Patel

Headquarters: Atlanta

Pleiogenix is a clinical-stage bio-pharmaceutical company seeking to develop the next generation treatment for non-alcoholic steatohepatitis (NASH) / fibrosis.

CEO: Joseph Evans

Headquarters: Carlsbad, California

 

Temprian Therapeutics Inc. is a pharmaceutical startup company operating out of the MATTER incubator in Chicago. It is focusing on drug development targeting autoimmune disease. The primary indication of its TT01 drug is vitiligo.

CEO: Kettil Cedercreutz

 Headquarters: Chicago, IL

Check out participants in the Pitch Perfect competition here.

Each day of the week will feature a pitch competition highlighting five startups in these tracks – Health Services, Health IT, Medical Devices, Biopharma and Diagnostics. Presenters will highlight their vision for changing healthcare followed up by a Q&A with investor judges. Winners for each track will be announced on July 27 on our website.

All the sessions will be recorded and be available to attendees upon request.

MedCity Invest will be a full week deep-dive into Healthcare Investing. Register now with the code MCN50 for the early bird rate of $49 to access the 5 pitch competitions, keynotes, panels, virtual networking and more!

Picture: Getty Images

Avatar photo
Avatar photo

MedCity News

MedCity News publishes a series of important, powerful conversations on the business of healthcare with the help of key partners and sponsors.

Shares0
Shares0